In a surprise move, the FDA has named the longtime leader of its oncology department, Richard Pazdur, M.D., as the new ...

Amid a rise in misinformation and pseudoscientific beliefs, a new corporate push from Bayer seeks to remind Americans of the ...

Eli Lilly’s Zepbound push is getting a “Queer Eye” makeover with the help of fashion expert Tan France, who is joining the ...

Just five months after Novo Nordisk launched Wegovy in India, the Danish company has partnered (PDF) with Emcure ...

A recently launched campaign starring patients and scientists shows Sanofi in hot pursuit of scientific innovation. | A ...

The TV ad will run through Nov. 16 across major cable channels, including CNN, Fox News and ESPN, a BMS spokesperson told ...

The specialty pharmacy industry is in a state of transformation, fueled by the rise of complex, innovative therapies and the ...

As Catalent sets up shop in a new headquarters and refines its corporate image under the ownership of Novo Holdings, the CDMO ...

BridgeBio said Pfizer’s filing of a complaint with the NAD “is an attempt to bypass the FDA, the federal agency responsible for overseeing prescription drug advertising, and to challenge promotional ...

Even with Inflation Reduction Act (IRA)-related pressure looming for its top product, Teva Pharmaceuticals is continuing to ...

Akeso has data showing ivonescimab can extend the lives of patients with previously treated EGFR-mutated non-small cell lung ...

Less than three months into his tenure, Novo Nordisk’s new CEO has undeniably left his mark on the company, launching a ...